Concepedia

Reagan Kelly

RK

Statistics

Publications

22

Citations

1.4K

H-Index

16

Active since

1981

Affiliations

United States Food and Drug Administration(Current)

National Center for Toxicological Research

University of Michigan

ICF International (United States)

Medizinische Hochschule Hannover

Reagan Kelly is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

1981–2022

22

Publications

22

A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure

Stephen B. Liggett, Sharon Cresci, Reagan Kelly et al. · Nature Medicine · 2008 · 320 citations · Full text

, , +14

Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals.

Reagan Kelly, Robert D. Larsen, J G Bryant et al. · Proceedings of the National Academy of Sciences · 1994 · 190 citations · Full text

, , +18

Clinical and Genetic Modifiers of Long-Term Survival in Heart Failure

Sharon Cresci, Reagan Kelly, Thomas P. Cappola et al. · Journal of the American College of Cardiology · 2009 · 115 citations · Full text

, , +10

Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs

Minjun Chen, Huixiao Hong, Hong Fang et al. · Toxicological Sciences · 2013 · 113 citations · Full text

Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps)

Zhichao Liu, Qiang Shi, Don Ding et al. · PLoS Computational Biology · 2011 · 96 citations · Full text

, , +20

Rows per page

1–5 of 22